MetaCap

Onconetix (ONCO) vs 60 Degrees Pharmaceuticals (SXTP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Onconetix is the larger company by market cap ($3.4 million vs $3.4 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

ONCO versus SXTP key metrics
MetricONCOSXTP
Share price$0.6543$0.9725
Market cap$3.43M$3.42M
1-day change+9.56%-11.59%
P/E ratio (TTM)0.00—
EPS (TTM)$310.39$-5.34
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$209.50$8.62
52-week low$0.58$0.84
Distance from 52-week high-99.69%-88.72%
Average volume2.23M129.77K
Shares outstanding5.24M3.52M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

ONCO vs SXTP FAQ

Which is bigger, Onconetix or 60 Degrees Pharmaceuticals?

Onconetix (ONCO) is larger, with a market capitalization of $3.43M compared with $3.42M for 60 Degrees Pharmaceuticals (SXTP).

Are Onconetix and 60 Degrees Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons